{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:05:23Z","timestamp":1770066323746,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-563","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T02:07:58Z","timestamp":1385863678000},"source":"Crossref","is-referenced-by-count":40,"title":["Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis"],"prefix":"10.1186","volume":"13","author":[{"given":"Francesco Giuseppe","family":"De Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesta","family":"Audisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Frairia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Busca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Marmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"issue":"9","key":"2768_CR1","first-page":"1409","volume":"124","author":"LN Han","year":"2011","unstructured":"Han LN, Zhou J, Shuringa JJ, Vellenga E: Treatment strategies in acute myeloid leukemia. Chin Med J (Engl). 2011, 124 (9): 1409-1421.","journal-title":"Chin Med J (Engl)"},{"key":"2768_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/asheducation-2011.1.43","volume":"2011","author":"GJ Roboz","year":"2011","unstructured":"Roboz GJ: Novel approaches to the treatment of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2011, 2011: 43-50. 10.1182\/asheducation-2011.1.43.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"2768_CR3","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2010","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al: IDSA guidelines clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010, 52 (4): e56-e93.","journal-title":"Clin Infect Dis"},{"key":"2768_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1086\/598624","volume":"29","author":"KV Rolston","year":"1999","unstructured":"Rolston KV: New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin Infect Dis. 1999, 29: 515-521. 10.1086\/598624.","journal-title":"Clin Infect Dis"},{"key":"2768_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, et al: Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005, 353: 977-987. 10.1056\/NEJMoa044097.","journal-title":"N Engl J Med"},{"key":"2768_CR6","first-page":"25","volume":"1","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M, et al: Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev. 2012, 1: 25-27.","journal-title":"Cochrane Database Syst Rev"},{"key":"2768_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1086\/513943","volume":"26","author":"DW Denning","year":"1998","unstructured":"Denning DW: Invasive aspergillosis. Clin Infect Dis. 1998, 26: 781-805. 10.1086\/513943.","journal-title":"Clin Infect Dis"},{"key":"2768_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, et al: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002, 34: 7-14. 10.1086\/323335.","journal-title":"Clin Infect Dis"},{"key":"2768_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJM200201243460402","volume":"346","author":"L Corey","year":"2002","unstructured":"Corey L, Boeckh M: Persistent fever in patients with neutropenia. N Engl J Med. 2002, 346: 222-224. 10.1056\/NEJM200201243460402.","journal-title":"N Engl J Med"},{"key":"2768_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1017\/S0950268809991208","volume":"138","author":"CY Chen","year":"2010","unstructured":"Chen CY, Tsay W, Tang GL, et al: Epidemiology of bloodstream infections in patients with hematological malignancies with and without neutropenia. Epidemiol Infect. 2010, 138: 1044-1051. 10.1017\/S0950268809991208.","journal-title":"Epidemiol Infect"},{"key":"2768_CR11","volume-title":"Abstracts of the Fifteenth EHA Annual Meeting","author":"T Intermesoli","year":"2010","unstructured":"Intermesoli T, Oldani E, Rossi G, et al: Two-step response-oriented induction predicts long-term outcome of adult patients with standard- and high-risk acute myeloid leukaemia (AML): a Northern Italy Leukaemia Group (NILG) study. Abstracts of the Fifteenth EHA Annual Meeting. 2010, Barcelona: Abstract 649. European Hematology Association"},{"issue":"6","key":"2768_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s15010-011-0201-x","volume":"39","author":"FG De Rosa","year":"2011","unstructured":"De Rosa FG, Pagani N, Fossati L, et al: The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection. 2011, 39 (6): 555-561. 10.1007\/s15010-011-0201-x.","journal-title":"Infection"},{"issue":"1","key":"2768_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1399-3062.2011.00650.x","volume":"14","author":"A Busca","year":"2012","unstructured":"Busca A, Cavecchia I, Locatelli F, et al: Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis. 2012, 14 (1): 40-48. 10.1111\/j.1399-3062.2011.00650.x.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"2768_CR14","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/AAC.00009-11","volume":"55","author":"M Tumbarello","year":"2011","unstructured":"Tumbarello M, Trecarichi EM, Bassetti M, et al: Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother. 2011, 55 (7): 3485-3490. 10.1128\/AAC.00009-11.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-563\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T12:40:56Z","timestamp":1548247256000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-563","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"563"}}